30.06.2024 |
Eran Ben-Arye MD a b
,
Jun Mao MD c
, Eduardo Bruera MD d,
Noah Samuels MD e
,
Yael Keshet PhD f
,
Richard T. Lee MD g
,
Dina Ben-Yehuda MD h
,
Elon Eisenberg MD b i
,
Gil Bar-Sela MD j
,
Pesach Shvartzman MD k
,
Lynda G. Balneaves RN l
,
Michal Shani MD m n
,
Martin Ellis MD o
,
Debu Tripathy MD p
,
Shifra Ash MD q
,
Avishay Elis MD r
,
Zvi Vaknin MD s t
,
Ruth Ofir RN u
,
Elad Schiff MD
Abstract
Context and objectives
To explore the feasibility of implementing the joint guideline on integrative medicine for pain management in oncology, published by the Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO), for integrative oncology (IO) services in supportive and palliative care.
Methods
A qualitative research methodology was co-designed by the SIO-ASCO guideline committee, with the Society for Complementary Medicine, Israel Medical Association (IMA). A questionnaire with five open-ended questions exploring barriers and enablers to implementing the guideline was distributed to chairs and board members of nine IMA-affiliated medical societies; four deans of Israeli medical schools; and nurses from the Israeli Society for Oncology Nursing. Respondent narratives were qualitatively analyzed using ATLAS.Ti software for systematic coding.
https://doi.org/10.1016/j.jpainsymman.2023.09.022